Abivax (AAVXF) Non-Current Debt (2021 - 2026)

Abivax has reported Non-Current Debt for 6 years, with the latest figure at $405078.0 in Q1 2026.

• On a quarterly basis, Non-Current Debt fell 98.42% year-over-year to $405078.0 in Q1 2026; TTM through Mar 2026 was $405078.0, a 98.42% decrease from a year earlier, with the FY2025 full-year figure at $644880.1, changed N/A from the prior year.
• Non-Current Debt was $405078.0 for Q1 2026 at Abivax, down from $644880.1 in the prior quarter.
• The five-year high for Non-Current Debt was $25.6 million in Q1 2025, with the low at $405078.0 in Q1 2026.
• Average Non-Current Debt over 5 years is $8.9 million, with a median of $3.7 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Non-Current Debt surged 658.52% in 2025, then slumped 98.42% in 2026.
• Over 5 years, Non-Current Debt stood at $3.6 million in 2022, then advanced by 5.1% to $3.8 million in 2023, then fell by 29.26% to $2.7 million in 2024, then plunged by 75.85% to $644880.1 in 2025, then sank by 37.19% to $405078.0 in 2026.
• The last three Non-Current Debt figures came in at $405078.0 (Q1 2026), $644880.1 (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.